QA: AILERON THERAPEUTICS INC in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001420565_2018_AILERON_THERAPEUTICS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001420565')"}

Graph

Absolute values for 0001420565, AILERON THERAPEUTICS INC

  xvar xval
0 AssetsCurrent 51,840,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 154,000
3 remainder_Assets 694,000
4 LiabilitiesCurrent 4,891,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,769,000
9 ResearchAndDevelopmentExpense 14,239,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 404,000
13 remainder_ComprehensiveNetIncome -33,000
  yvar yval
0 Assets 52,688,000
1 Liabilities 4,891,000
2 Expenses 23,008,000
3 Revenues 0
4 StockholdersEquity 47,797,000
5 NetIncome -22,604,000
6 ComprehensiveNetIncome -22,620,500
7 BaseVar 40,512,000
8 EconomicCapitalRatio 2.07

Edgar->Model Mapping

Feature Distribution

Change over Time